Biodexa Partners with Animo for Clinical Trial Recruitment Campaign

Animo to Drive Recruitment Campaign for Biodexa Pharmaceuticals' Brain Tumor Study

London, June 2023 - Biodexa Pharmaceuticals has enlisted the expertise of Animo as their creative agency for an upcoming USA-based clinical study on a groundbreaking brain tumour treatment. The collaboration aims to develop a comprehensive campaign, including an overarching positioning, highlighting the study's significance. They will also create a patient information website as a valuable resource, design engaging event materials, and produce explainer videos to simplify complex medical information.

This strategic partnership between Biodexa Pharmaceuticals and Animo aims to enhance patient recruitment efforts, ensuring that potential participants are well-informed and engaged in the pioneering brain tumour study. The campaign launch date coincides with the American Brain Tumour Association Conference in Chicago in September 2023, adding a significant platform for outreach and contributing to the advancement of brain tumour treatments and patient care. Simon Culley, co-founder and director at Animo was eager to emphasise that:  

“Biodexa are an incredible organisation making life-changing developments in the treatment of cancer. So it is a real privilege to be able to support them in developing this revolutionary new treatment, and in some small way contribute to the ongoing fight against cancer whilst improving the lives of the people it touches.”